Bone Biologics Corp (BBLG): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$6.68M
As of 2021-12-31
+91.2%
3-year compound annual growth
+60.8%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2021-12-31 | $6.68M | n/a | 2022-03-15, Balance as of period end |
| No annual figure between 2019-12-31 and 2021-12-31. | |||
| 2019-12-31 | $24.1K | -97.5% | 2021-04-15, Balance as of period end |
| 2018-12-31 | $955.4K | +38.4% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $690.3K | n/a | 2019-03-29, Balance as of period end |
| 2017-09-30 | $1.62M | n/a | 2018-04-02, Balance as of period end |
| 2017-06-30 | $783.0K | n/a | 2018-04-02, Balance as of period end |
| 2017-03-31 | $1.61M | n/a | 2018-04-02, Balance as of period end |
| 2016-12-31 | $620.4K | n/a | 2018-04-02, Balance as of period end |
| 2016-09-30 | $688.2K | n/a | 2018-04-02, Balance as of period end |
| 2016-06-30 | $2.19M | n/a | 2018-04-02, Balance as of period end |
| 2016-03-31 | $4.22M | n/a | 2018-04-02, Balance as of period end |
| 2015-12-31 | $1.12M | -58.1% | 2017-03-30, Balance as of period end |
| 2014-12-31 | $2.66M | n/m | 2016-03-28, Balance as of period end |
| 2013-12-31 | $1.5K | n/a | 2015-03-31, Balance as of period end |
| 2013-10-31 | $380 | -24.0% | 2014-02-13, Balance as of period end |
| 2012-10-31 | $500 | n/a | 2014-02-13, Balance as of period end |
| 2011-10-31 | $0 | n/a | 2013-01-29, Balance as of period end |